GPT-Rosalind (OpenAI) vs Hunyuan 3 (Tencent Hy3)

Which one should you pick? Here's the full breakdown.

GPT-Rosalind (OpenAI)

C
6.8/10

OpenAI's first domain-specific model -- life sciences, drug discovery, translational medicine. Launched 2026-04-16 as a Trusted Access research preview. Launch partners: Amgen, Moderna, Allen Institute, Thermo Fisher. Paired with a Life Sciences Codex plugin (50+ scientific tool integrations)

Our Pick

Hunyuan 3 (Tencent Hy3)

A
8.1/10

Tencent's Hy3 Preview launched 2026-04-23 -- 295B total / 21B active MoE, 256K context, open-sourced on HuggingFace under tencent/Hy3-preview. Cheapest frontier-class API at ~1.2 RMB per million input tokens. Integrated into Yuanbao, WeChat, QQ

CategoryGPT-Rosalind (OpenAI)Hunyuan 3 (Tencent Hy3)
Ease of Use3.07.0
Output Quality9.08.0
Value7.09.5
Features8.08.0
Overall6.88.1

Pricing Comparison

FeatureGPT-Rosalind (OpenAI)Hunyuan 3 (Tencent Hy3)
Free TierNoYes
Starting PriceInvite only$0

Which Should You Pick?

Pick GPT-Rosalind (OpenAI) if...

  • Higher output quality (9 vs 8)

Researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get Trusted Access. Also relevant to anyone building life-sciences AI products who needs to understand where OpenAI's vertical strategy is heading.

Visit GPT-Rosalind (OpenAI)

Pick Hunyuan 3 (Tencent Hy3) if...

  • Easier to use (7 vs 3)
  • Better value for money (9.5/10)
  • Has a free tier

Chinese-market builders, multilingual products that need strong CN performance, and cost-sensitive developers who want frontier-class quality at sub-DeepSeek pricing. Also anyone watching the open-weights field who wants Tencent's distribution-backed entry on the bench.

Visit Hunyuan 3 (Tencent Hy3)

Our Verdict

Hunyuan 3 (Tencent Hy3) is the clear winner here with 8.1/10 vs 6.8/10. GPT-Rosalind (OpenAI) isn't bad, but Hunyuan 3 (Tencent Hy3) outperforms it across the board. Pick GPT-Rosalind (OpenAI) only if researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get trusted access.